Senticell’s cell-based diagnostics platform is engineered for ultra-sensitive, same-day molecular testing that analyzes disease-specific DNA, RNA, and protein biomarkers carried by red blood cells (RBCs).

Through cfDNA and tDNA liquid biopsy technology, RBCs capture and preserve molecular signals from the body’s tissue microenvironment, enabling early, accurate, and non-invasive disease detection across oncology, infection, and autoimmune applications.

The RBC-based diagnostic platform delivers a rapid, low-cost, and highly scalable solution-capable of identifying genetic mutations, immune signatures, and molecular biomarkers from a single drop of blood, transforming how diseases are monitored and treated in precision medicine.